Validation of immune thrombocytopenia diagnosis code in the French hospital electronic database

  • Guillaume Moulis
    Correspondence
    Corresponding author at: Service de Médecine Interne, pavillon URM, CHU Purpan, place du Dr Baylac, TSA 40031, 31059 Toulouse Cedex 9, France. Tel.: +33 561 779 677; fax: +33 561 778 058.
    Affiliations
    UMR 1027, INSERM, Faculté de Médecine, Université de Toulouse III, Toulouse, France

    Service de Médecine Interne, Centre Hospitalier Universitaire de Toulouse, Toulouse, France

    CIC 1436, Centre Hospitalier Universitaire de Toulouse, Toulouse, France
    Search for articles by this author
  • Johanne Germain
    Affiliations
    CIC 1436, Centre Hospitalier Universitaire de Toulouse, Toulouse, France
    Search for articles by this author
  • Daniel Adoue
    Affiliations
    Service de Médecine Interne et Immunopathologie clinique, Centre Hospitalier Universitaire de Toulouse, Toulouse, France
    Search for articles by this author
  • Odile Beyne-Rauzy
    Affiliations
    Service de Médecine Interne et Immunopathologie clinique, Centre Hospitalier Universitaire de Toulouse, Toulouse, France
    Search for articles by this author
  • Hélène Derumeaux
    Affiliations
    UMR 1027, INSERM, Faculté de Médecine, Université de Toulouse III, Toulouse, France

    Département d'Information Médicale, Centre Hospitalier Universitaire de Toulouse, Toulouse, France
    Search for articles by this author
  • Laurent Sailler
    Affiliations
    UMR 1027, INSERM, Faculté de Médecine, Université de Toulouse III, Toulouse, France

    Service de Médecine Interne, Centre Hospitalier Universitaire de Toulouse, Toulouse, France

    CIC 1436, Centre Hospitalier Universitaire de Toulouse, Toulouse, France
    Search for articles by this author
  • Maryse Lapeyre-Mestre
    Affiliations
    UMR 1027, INSERM, Faculté de Médecine, Université de Toulouse III, Toulouse, France

    CIC 1436, Centre Hospitalier Universitaire de Toulouse, Toulouse, France

    Service de Pharmacologie Médicale et Clinique, Faculté de Médecine, Centre Hospitalier Universitaire de Toulouse, Toulouse, France
    Search for articles by this author
Published:March 21, 2016DOI:https://doi.org/10.1016/j.ejim.2016.02.021
      Immune thrombocytopenia (ITP) is a rare autoimmune disorder leading to platelet destruction and inadequate platelet production, resulting in a risk of spontaneous bleeding. The incidence of ITP necessitating health care is estimated to be 2.9/100 000 inhabitants [
      • Moulis G.
      • Palmaro A.
      • Montastruc J.-L.
      • Godeau B.
      • Lapeyre-Mestre M.
      • Sailler L.
      Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France.
      ].

      Keywords

      To read this article in full you will need to make a payment

      References

        • Moulis G.
        • Palmaro A.
        • Montastruc J.-L.
        • Godeau B.
        • Lapeyre-Mestre M.
        • Sailler L.
        Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France.
        Blood. 2014; 124: 3308-3315
        • Neunert C.
        • Arnold D.M.
        Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review: reply.
        J Thromb Haemost. 2015; 13: 1522-1523
        • Moulis G.
        • Lapeyre-Mestre M.
        • Palmaro A.
        • Pugnet G.
        • Montastruc J.-L.
        • Sailler L.
        French health insurance databases: what interest for medical research?.
        Rev Médecine Interne Fondée Par Société Natl Francaise Médecine Interne. 2015; 36: 411-417
        • Rodeghiero F.
        • Stasi R.
        • Gernsheimer T.
        • Michel M.
        • Provan D.
        • Arnold D.M.
        • et al.
        Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group.
        Blood. 2009; 113: 2386-2393
        • Moulis G.
        • Sailler L.
        • Adoue D.
        • Lapeyre-Mestre M.
        Pharmacoepidemiology of immune thrombocytopenia: protocols of FAITH and CARMEN studies.
        Therapie. 2014; 69: 437-448
        • Heden K.E.K.
        • Jensen A.Ø.
        • Farkas D.K.
        • Nørgaard M.
        Validity of a procedure to identify patients with chronic idiopathic thrombocytopenic purpura in the Danish National Registry of patients.
        Clin Epidemiol. 2009; 1: 7-10
        • Schoonen W.M.
        • Kucera G.
        • Coalson J.
        • Li L.
        • Rutstein M.
        • Mowat F.
        • et al.
        Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database.
        Br J Haematol. 2009; 145: 235-244
        • Segal J.B.
        • Powe N.R.
        Accuracy of identification of patients with immune thrombocytopenic purpura through administrative records: a data validation study.
        Am J Hematol. 2004; 75: 12-17
        • Terrell D.R.
        • Beebe L.A.
        • Vesely S.K.
        • Neas B.R.
        • Segal J.B.
        • George J.N.
        Determining a definite diagnosis of primary immune thrombocytopenia by medical record review.
        Am J Hematol. 2012; 87: 843-847